内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

糖尿病前期病证结合诊疗指南

2021-03-02 中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会 世界中医药

糖尿病

糖尿病前期指在正常血糖与糖尿病之间的中间高血糖状态。糖尿病前期的患病率高达35.2%,其中男性为37.0%,女性为33.4%。

中文标题：

糖尿病前期病证结合诊疗指南

发布机构：

中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会

发布日期：

2021-03-02

简要介绍：

糖尿病前期指在正常血糖与糖尿病之间的中间高血糖状态[1]。糖尿病前期的患病率高达35.2%,其中男性为37.0%,女性为33.4%[2]。糖尿病前期属于中医"脾瘅""肥胖""食郁"等范畴,中医药防治糖尿病前期有新的证据,是"治未病"理论的充分体现[3-4]。

相关资料下载：
[AttachmentFileName(sort=1, fileName=糖尿病前期病证结合诊疗指南(2021-03-02).pdf)] GetToolGuiderByIdResponse(projectId=1, id=918821c0022e91b4, title=糖尿病前期病证结合诊疗指南, enTitle=, guiderFrom=世界中医药, authorId=0, author=, summary=糖尿病前期指在正常血糖与糖尿病之间的中间高血糖状态。糖尿病前期的患病率高达35.2%,其中男性为37.0%,女性为33.4%。, cover=https://img.medsci.cn/20211130/1638249632673_5579292.png, journalId=0, articlesId=null, associationId=2186, associationName=中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会, associationIntro=中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会, copyright=0, guiderPublishedTime=Tue Mar 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">糖尿病前期指在正常血糖与糖尿病之间的中间高血糖状态[1]。糖尿病前期的患病率高达35.2%,其中男性为37.0%,女性为33.4%[2]。糖尿病前期属于中医"脾瘅""肥胖""食郁"等范畴,中医药防治糖尿病前期有新的证据,是"治未病"理论的充分体现[3-4]。</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2691, appHits=252, showAppHits=0, pcHits=541, showPcHits=2439, likes=0, shares=15, comments=11, approvalStatus=1, publishedTime=Tue Nov 30 13:43:01 CST 2021, publishedTimeString=2021-03-02, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 30 13:25:02 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 12:06:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=糖尿病前期病证结合诊疗指南(2021-03-02).pdf)])
糖尿病前期病证结合诊疗指南(2021-03-02).pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1204265, encodeId=3487120426501, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f66d5431628, createdName=ms3000001516547280, createdTime=Sun Mar 20 09:48:39 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193691, encodeId=ad9c119369114, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:19:07 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193686, encodeId=55741193686fa, content=谢谢，学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:17:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183825, encodeId=607b118382504, content=没有看到，如何评价？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ecb1590724, createdName=zhszh3, createdTime=Thu Jan 13 10:38:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077614, encodeId=724a10e76149f, content=完全是中医诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02652902302, createdName=414104166, createdTime=Tue Dec 07 08:00:17 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-03-20 ms3000001516547280

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1204265, encodeId=3487120426501, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f66d5431628, createdName=ms3000001516547280, createdTime=Sun Mar 20 09:48:39 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193691, encodeId=ad9c119369114, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:19:07 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193686, encodeId=55741193686fa, content=谢谢，学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:17:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183825, encodeId=607b118382504, content=没有看到，如何评价？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ecb1590724, createdName=zhszh3, createdTime=Thu Jan 13 10:38:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077614, encodeId=724a10e76149f, content=完全是中医诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02652902302, createdName=414104166, createdTime=Tue Dec 07 08:00:17 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-02-15 1351fc2f66m

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1204265, encodeId=3487120426501, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f66d5431628, createdName=ms3000001516547280, createdTime=Sun Mar 20 09:48:39 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193691, encodeId=ad9c119369114, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:19:07 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193686, encodeId=55741193686fa, content=谢谢，学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:17:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183825, encodeId=607b118382504, content=没有看到，如何评价？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ecb1590724, createdName=zhszh3, createdTime=Thu Jan 13 10:38:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077614, encodeId=724a10e76149f, content=完全是中医诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02652902302, createdName=414104166, createdTime=Tue Dec 07 08:00:17 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-02-15 1351fc2f66m

    谢谢，学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1204265, encodeId=3487120426501, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f66d5431628, createdName=ms3000001516547280, createdTime=Sun Mar 20 09:48:39 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193691, encodeId=ad9c119369114, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:19:07 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193686, encodeId=55741193686fa, content=谢谢，学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:17:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183825, encodeId=607b118382504, content=没有看到，如何评价？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ecb1590724, createdName=zhszh3, createdTime=Thu Jan 13 10:38:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077614, encodeId=724a10e76149f, content=完全是中医诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02652902302, createdName=414104166, createdTime=Tue Dec 07 08:00:17 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-01-13 zhszh3

    没有看到，如何评价？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1204265, encodeId=3487120426501, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f66d5431628, createdName=ms3000001516547280, createdTime=Sun Mar 20 09:48:39 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193691, encodeId=ad9c119369114, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:19:07 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193686, encodeId=55741193686fa, content=谢谢，学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Tue Feb 15 18:17:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183825, encodeId=607b118382504, content=没有看到，如何评价？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ecb1590724, createdName=zhszh3, createdTime=Thu Jan 13 10:38:33 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077614, encodeId=724a10e76149f, content=完全是中医诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02652902302, createdName=414104166, createdTime=Tue Dec 07 08:00:17 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-07 414104166

    完全是中医诊疗指南

    0

相关指南

2021 NICE临床指南：成人2型糖尿病的管理

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-11-24

2021 JBDS-IP指南：急诊处理与血糖相关的紧急情况

英国糖尿病协会联合住院治疗组(JBDS-IP,Joint British Diabetes Societiesfor Inpatient Care Group) · 2021-09-01

2021 JBDS-IP指南：糖尿病住院患者的自我管理（8月修订）

英国糖尿病协会联合住院治疗组(JBDS-IP,Joint British Diabetes Societiesfor Inpatient Care Group) · 2021-08-01

2021更新 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-07-21

成人2型糖尿病基础胰岛素起始调量期专家指导意见

中国内分泌相关专家小组（统称） · 2021-10-15

无症状糖尿病患者冠状动脉疾病的风险分层和筛查：法国心血管学会和法国糖尿病学会立场文件

法国心血管学会(FSC,French Society of Cardiology) · 2021-11-01

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01